Provision of Clinical Trial Monitoring to the FaR-RMS Trial
The FaR-RMS trial The University of Birmingham Cancer Research Clinical Trials Unit are working on a collaboration with a large Pharmaceutical company to add a new arm to an existing study. The trial is a multicentre, randomised phase II trial evaluating the new therapy against a control arm in paediatric patients with relapsed/refractory rhabdomyosarcoma. Patients will receive therapy for up to 12 cycles (approx. 12 months) and will be followed-up for 5 years.
Buyer
Tender for the Provision of Clinical Trial Monitoring to the FaR-RMS Trial
Value
Not provided
Published
31 Mar 2021
Closes
30 Apr 2021
Procurement details
Source
Find a Tender
Region
Birmingham
Procurement method
Open
Category
Services
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
73300000
Design and execution of research and development
48814400
Clinical information system
33195000
Patient-monitoring system
Lots
Lot 1 Provision of Clinical Trial Monitoring to the FaR-RMS Trial
Value not provided
The University of Birmingham Cancer Research Clinical Trials Unit are working on a collaboration with a large Pharmaceutical company to add a new arm to an existing study. The trial is a multicentre, randomised phase II trial evaluating the new therapy against a control arm in paediatric patients with relapsed/refractory rhabdomyosarcoma. Patients will recei...
Delivery: Birmingham
Documents
No document metadata is available for this public record.
Contains public sector information licensed under the Open Government Licence v3.0.